What types of samples can Creative Biolabs accept for antigen-specific TCR repertoire analysis?

Creative Biolabs typically works with human or animal peripheral blood mononuclear cells (PBMCs), but we can also process lymphocyte-rich material from tissues, spleen, or lymph nodes. For projects with limited input, our optimized protocols allow reliable sequencing from very small cell numbers.

How rare are antigen-specific T cells, and can your platform capture them effectively?

Antigen-specific T cells often occur at frequencies as low as one in 10,000 within the total T cell population. Through our enrichment strategies—MHC multimer staining, activation marker assays, or computational inference—Creative Biolabs can reliably isolate and analyze these rare populations, ensuring they are represented in the final dataset.

Can Creative Biolabs help interpret biological significance beyond the sequencing results?

Yes. While our primary deliverable is high-quality sequencing and analysis, our team of immunologists and bioinformaticians is available to discuss findings in the context of your research. Many clients find this consultation especially useful for designing follow-up experiments.

TCR Repertoire Analysis Service for Antigen Specific T Cell Identification

Strategy Framework Features Testimonials FAQ

The immune system is orchestrated by an enormous diversity of T cells, each programmed to recognize a specific molecular target. Among this vast army, antigen-specific T cells are exceptionally rare—often one in ten thousand. Detecting, enriching, and decoding these unique cells has become a cornerstone of modern immunology research. At Creative Biolabs, we have developed a robust platform that enables researchers to uncover the antigen-specific TCR (T cell receptor) repertoire with exceptional precision.

By combining state-of-the-art enrichment technologies with next-generation sequencing (NGS), Creative Biolabs provides scientists with reliable, high-depth data that reveal which TCRs are engaged in an immune response. Whether your focus is viral immunity, autoimmune mechanisms, or vaccine development, our services are designed to empower discovery while maintaining scientific rigor.

Our Strategy for Unlocking Antigen-Specific TCRs

Traditional bulk sequencing of T cells provides an overall repertoire profile but fails to distinguish which clones are relevant to a particular antigen. Creative Biolabs overcomes this limitation by employing specialized enrichment strategies before sequencing, ensuring that only the most relevant T cells are captured and analyzed.

Our standard workflow integrates three major approaches, tailored to the needs of each project:

Precision Labeling via MHC Multimer Technology

Synthetic antigen peptides are loaded onto engineered MHC complexes.
These complexes are assembled into multimeric "baits" tagged with fluorophores.
When mixed with a T cell sample, only TCRs with perfect specificity bind and become traceable.
Fluorescence-activated cell sorting (FACS) isolates the rare positive cells for sequencing.

Functional Identification through Activation Marker Assays

Samples are stimulated with the antigen of interest.
Responsive T cells upregulate distinct surface proteins such as CD137, OX40, or CD69.
Fluorescent antibodies bind to these markers, enabling FACS-based isolation of functional responders.
Sequencing then captures the repertoire of truly active, antigen-specific clones.

Computational Tracking of Expanding Clones

Samples are collected at multiple time points surrounding an immune challenge (e.g., pre- and post-vaccination).
Bulk TCR sequencing is performed at each stage.
Sophisticated algorithms identify clones that expand significantly, highlighting likely antigen-driven responses.

By applying one or more of these strategies, Creative Biolabs delivers a high-confidence list of candidate TCRs associated with your antigen of interest.

Need strategic advice? Reach out!

Step-by-Step Service Framework

To provide clarity on how we deliver results, below is a simplified outline of our isolation and sequencing pipeline:

Fig.1 Sample Processing. (Creative Biolabs AI)

01 Sample Preparation

At Creative Biolabs, the process begins with meticulous sample handling. Peripheral blood mononuclear cells (PBMCs) are the most common starting material, though we can also accommodate lymphocyte-rich samples from tissue or other biofluids. We apply density gradient centrifugation or equivalent isolation techniques to ensure a clean lymphocyte population. From the outset, strict attention is given to maintaining cell viability—temperature, buffer composition, and handling times are tightly controlled to prevent stress-induced artifacts. For projects involving limited material, we employ protocols optimized for low-input samples, enabling reliable downstream sequencing even from scarce populations.

Inquire with us

Fig.2 Target Antigen Enrichment. (Creative Biolabs AI)

02 Antigen-Specific Enrichment

Bulk sequencing alone cannot pinpoint the few T cells relevant to your antigen of interest. Creative Biolabs employs enrichment strategies tailored to your project goals. Using MHC multimer staining, we craft customized peptide-MHC complexes that selectively bind to target TCRs with high avidity. For functional assays, we stimulate T cells with defined antigens under controlled conditions and track activation-induced markers such as CD137, OX40, and CD69. This ensures we capture only those cells that have responded in a biologically meaningful way. In longitudinal studies, we compare repertoire shifts before and after antigen exposure, using computational inference to detect clones that have undergone dramatic expansion. These enrichment methods maximize specificity while minimizing background noise.

Inquire with us

Fig.3 Cell Separation and Sorting. (Creative Biolabs AI)

03 Cell Sorting

Once antigen-specific populations are labeled, the next step is high-purity isolation. Our advanced fluorescence-activated cell sorting (FACS) systems are calibrated for precision and reproducibility. Sorting parameters are carefully set to distinguish true positive events from non-specific signals, with appropriate controls run in parallel. This process physically separates rare antigen-responsive cells—sometimes as few as one in ten thousand—from the bulk population. The end result is a highly purified collection of cells ready for molecular analysis, with minimal contamination from irrelevant T cell subsets.

Inquire with us

Fig.4 Molecular Isolation. (Creative Biolabs AI)

04 Molecular Extraction

From these sorted cells, we isolate nucleic acids—either RNA or genomic DNA, depending on the scope of the project. For RNA-based protocols, immediate stabilization is essential to prevent degradation, and our extraction methods are designed to maximize yield from even very low cell numbers. DNA-based workflows are equally optimized, ensuring that both TCR α and β chain genes are preserved intact. Every step, from lysis to purification, is performed under stringent quality controls. The extracted material is then quantified and checked for integrity before entering the sequencing library preparation stage.

Inquire with us

Fig.5 Sequencing Library Preparation. (Creative Biolabs AI)

05 NGS Library Construction

Library preparation is the critical bridge between raw biological material and actionable sequencing data. At Creative Biolabs, we employ specialized library kits and workflows designed for TCR profiling. Both the α and β chain regions are amplified with high-fidelity polymerases, minimizing artifacts that could distort clonotype analysis. Unique molecular identifiers (UMIs) are incorporated to track individual molecules and reduce PCR bias. Adaptors compatible with major sequencing platforms are added, ensuring high sequencing depth and read quality. Each library undergoes rigorous QC steps—fragment size analysis, concentration checks, and trial sequencing runs—before proceeding to full-scale next-generation sequencing.

Inquire with us

06 Bioinformatics Pipeline

Raw sequencing reads are only the beginning. Creative Biolabs' bioinformatics team applies a multi-layered analysis pipeline designed specifically for TCR repertoire profiling. Reads are first quality-trimmed and aligned to reference V, D, and J gene segments. Clonotypes are then assembled, with error correction applied to remove sequencing artifacts. From there, we generate comprehensive repertoire statistics, including diversity indices, clone size distributions, and antigen-driven expansions. Advanced clustering algorithms can highlight sequence convergence across samples or subjects, and comparative analyses enable tracking of dynamic changes over time or between conditions. The pipeline is continuously updated with the latest algorithms to ensure accuracy and depth.

Inquire with us

Why Researchers Choose Creative Biolabs

Scientific Precision

Our protocols minimize background noise and false positives, ensuring that the TCRs identified are genuinely antigen-driven.

Tailored Solutions

Creative Biolabs does not rely on a one-size-fits-all model. Each project is customized based on sample type, antigen characteristics, and research objectives.

High-Throughput Capacity

Ability to analyze thousands of clonotypes across multiple conditions in parallel.

Data Depth and Transparency

We provide not only high-quality sequencing data but also detailed interpretive analysis that enables researchers to draw meaningful conclusions.

Explore our features now!

Insights from Our Customers

Researchers who have partnered with Creative Biolabs often highlight not just the technical performance, but also the collaborative spirit of our team. A recent client in academic immunology commented:

"Working with Creative Biolabs gave us clarity on the antigen-specific TCRs involved in our viral infection model. Their team provided actionable insights that went far beyond raw sequencing data. It felt like a true partnership, not just a service."

Another scientist from a university vaccine research group shared:

"We had tried standard bulk repertoire sequencing before, but it was Creative Biolabs' enrichment and analysis that finally revealed which TCR clones were truly responsive. The depth and precision of their results exceeded our expectations."

Inquire about client stories!

If your research demands a reliable partner for uncovering antigen-specific T cell repertoires, Creative Biolabs is uniquely positioned to deliver. From initial project consultation to final data interpretation, our team is committed to scientific accuracy, transparency, and client satisfaction. Contact our team today to discuss your project and see how we can support your TCR discovery efforts.

Frequently Asked Questions

Q: What types of samples can Creative Biolabs accept for antigen-specific TCR repertoire analysis?
A: Creative Biolabs typically works with human or animal peripheral blood mononuclear cells (PBMCs), but we can also process lymphocyte-rich material from tissues, spleen, or lymph nodes. For projects with limited input, our optimized protocols allow reliable sequencing from very small cell numbers.
Q: How rare are antigen-specific T cells, and can your platform capture them effectively?
A: Antigen-specific T cells often occur at frequencies as low as one in 10,000 within the total T cell population. Through our enrichment strategies—MHC multimer staining, activation marker assays, or computational inference—Creative Biolabs can reliably isolate and analyze these rare populations, ensuring they are represented in the final dataset.
Q: Can Creative Biolabs help interpret biological significance beyond the sequencing results?
A: Yes. While our primary deliverable is high-quality sequencing and analysis, our team of immunologists and bioinformaticians is available to discuss findings in the context of your research. Many clients find this consultation especially useful for designing follow-up experiments.

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

	USA: Europe: Germany:
	Call us at: USA: UK: Germany:
	Fax:
	Email: